318Tip Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in Stage II-III HER2-positive Breast Cancer: the TRAIN-4 Study F.M. Louis,A. van der Voort,C.P. Schröder,A.N. Scholten,J. Wesseling,M-J.T.F.D. Vrancken Peeters,R.M. Mann,G.S. SonkeAnnals of Oncology（2024）引用 0|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
